Argatroban promotes recovery of spinal cord injury by inhibiting the PAR1/JAK2/STAT3 signaling pathway

Argatroban is a synthetic thrombin inhibitor approved by U.S. Food and Drug Administration for the treatment of thrombosis. However, whether it plays a role in the repair of spinal cord injury is unknown. In this study, we established a rat model of T10 moderate spinal cord injury using an NYU Impac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chenxi, Zhou, Tiangang, Li, Ming, Liu, Jie, Zhao, Xiaoqing, Pang, Yilin, Liu, Xinjie, Zhang, Jiawei, Ma, Lei, Li, Wenxiang, Yao, Xue, Feng, Shiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503625/
https://www.ncbi.nlm.nih.gov/pubmed/37488908
http://dx.doi.org/10.4103/1673-5374.375345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503625/
https://www.ncbi.nlm.nih.gov/pubmed/37488908
http://dx.doi.org/10.4103/1673-5374.375345

Ejemplares similares